Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination. | Br J Cancer | 2023 | 37165202 | PubTator, text mining | PubMed |
| Zn[Formula: see text]Ni[Formula: see text]Te semiconductor nanocrystals in transparent glass for optoelectronic device applications. | Sci Rep | 2023 | 37165027 | PubTator, text mining | PubMed |
| SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. | J Transl Med | 2023 | 37147713 | PubTator, text mining | PubMed |
| Glucocorticoid regulation of cancer development and progression. | Front Endocrinol (Lausanne) | 2023 | 37143725 | PubTator, text mining | PubMed |
| An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. | Pharmaceutics | 2023 | 37111758 | PubTator, text mining | PubMed |
| Antimetastatic Activity of Apoptolidin A by Upregulation of N-Myc Downstream-Regulated Gene 1 Expression in Human Colorectal Cancer Cells. | Pharmaceuticals (Basel) | 2023 | 37111248 | PubTator, text mining | PubMed |
| Influence of Citric Acid-Assisted Impregnation of Recycled Aggregate on the Properties of the Resultant Concrete. | Materials (Basel) | 2023 | 37109822 | PubTator, text mining | PubMed |
| Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers. | Int J Stem Cells | 2023 | 37105559 | PubTator, text mining | PubMed |
| NGS-Panel Diagnosis Developed for the Differential Diagnosis of Idiopathic Toe Walking and Its Application for the Investigation of Possible Genetic Causes for the Gait Anomaly. | Glob Med Genet | 2023 | 37091313 | PubTator, text mining | PubMed |
| Perinatal exposure to the fungicide ketoconazole alters hypothalamic control of puberty in female rats. | Front Endocrinol (Lausanne) | 2023 | 37077353 | PubTator, text mining | PubMed |
| Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression. | J Transl Med | 2023 | 37076857 | PubTator, text mining | PubMed |
| Guilt by Association: Stepwise Entanglement of the Role of Hypoxia-inducible Factor in Pulmonary Hypertension. | Am J Respir Cell Mol Biol | 2023 | 37075325 | PubTator, text mining | PubMed |
| DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy. | Clin Cancer Res | 2023 | 37058257 | PubTator, text mining | PubMed |
| Aid or Antagonize: Nuclear Long Noncoding RNAs Regulate Host Responses and Outcomes of Viral Infections. | Cells | 2023 | 37048060 | PubTator, text mining | PubMed |
| Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia. | Int J Mol Sci | 2023 | 37047450 | PubTator, text mining | PubMed |
| Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells. | Int J Mol Sci | 2023 | 37047218 | PubTator, text mining | PubMed |
| Tumor dormancy is closely related to prognosis prediction and tumor immunity in neuroblastoma. | Transl Pediatr | 2023 | 37035400 | PubTator, text mining | PubMed |
| Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis. | Ther Adv Med Oncol | 2023 | 37034479 | PubTator, text mining | PubMed |
| Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. | Front Immunol | 2023 | 37033921 | PubTator, text mining | PubMed |
| Single-cell protein activity analysis reveals a novel subpopulation of chondrocytes and the corresponding key master regulator proteins associated with anti-senescence and OA progression. | Front Immunol | 2023 | 37033917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=19